1.1 Research Scope 1.2 Market Segmentation 1.3 Research Objectives 1.4 Research Methodology 1.4.1 Research Process 1.4.2 Data Triangulation 1.4.3 Research Approach 1.4.4 Base Year 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.5.2 Covid-19 Impact: Commodity Prices Indices 1.5.3 Covid-19 Impact: Global Major Government Policy 1.6 The Covid-19 Impact on Biopharmaceutical Cmo & Cro Industry 1.7 COVID-19 Impact: Biopharmaceutical Cmo & Cro Market Trends 2 Global Biopharmaceutical Cmo & Cro Quarterly Market Size Analysis 2.1 Biopharmaceutical Cmo & Cro Business Impact Assessment - COVID-19 2.1.1 Global Biopharmaceutical Cmo & Cro Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.1.2 Global Biopharmaceutical Cmo & Cro Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.2 Global Biopharmaceutical Cmo & Cro Quarterly Market Size 2020-2021 2.3 COVID-19-Driven Market Dynamics and Factor Analysis 2.3.1 Drivers 2.3.2 Restraints 2.3.3 Opportunities 2.3.4 Challenges 3 Quarterly Competitive Assessment, 2020 3.1 Global Biopharmaceutical Cmo & Cro Quarterly Market Size by Manufacturers, 2019 VS 2020 3.2 Global Biopharmaceutical Cmo & Cro Factory Price by Manufacturers 3.3 Location of Key Manufacturers Biopharmaceutical Cmo & Cro Manufacturing Factories and Area Served 3.4 Date of Key Manufacturers Enter into Biopharmaceutical Cmo & Cro Market 3.5 Key Manufacturers Biopharmaceutical Cmo & Cro Product Offered 3.6 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on Biopharmaceutical Cmo & Cro Segments, By Type 4.1 Introduction 1.4.1 Biologics 1.4.2 Biosimilars 4.2 By Type, Global Biopharmaceutical Cmo & Cro Market Size, 2019-2021 4.2.1 By Type, Global Biopharmaceutical Cmo & Cro Market Size by Type, 2020-2021 4.2.2 By Type, Global Biopharmaceutical Cmo & Cro Price, 2020-2021 5 Impact of Covid-19 on Biopharmaceutical Cmo & Cro Segments, By Application 5.1 Overview 5.5.1 Contract Manufacturing 5.5.2 Contract Research 5.2 By Application, Global Biopharmaceutical Cmo & Cro Market Size, 2019-2021 5.2.1 By Application, Global Biopharmaceutical Cmo & Cro Market Size by Application, 2019-2021 5.2.2 By Application, Global Biopharmaceutical Cmo & Cro Price, 2020-2021 6 Geographic Analysis 6.1 Introduction 6.2 North America 6.2.1 Macroeconomic Indicators of US 6.2.2 US 6.2.3 Canada 6.3 Europe 6.3.1 Macroeconomic Indicators of Europe 6.3.2 Germany 6.3.3 France 6.3.4 UK 6.3.5 Italy 6.4 Asia-Pacific 6.4.1 Macroeconomic Indicators of Asia-Pacific 6.4.2 China 6.4.3 Japan 6.4.4 South Korea 6.4.5 India 6.4.6 ASEAN 6.5 Rest of World 6.5.1 Latin America 6.5.2 Middle East and Africa 7 Company Profiles 7.1 Lonza 7.1.1 Lonza Business Overview 7.1.2 Lonza Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.1.3 Lonza Biopharmaceutical Cmo & Cro Product Introduction 7.1.4 Lonza Response to COVID-19 and Related Developments 7.2 Boehringer Ingelheim GmbH 7.2.1 Boehringer Ingelheim GmbH Business Overview 7.2.2 Boehringer Ingelheim GmbH Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.2.3 Boehringer Ingelheim GmbH Biopharmaceutical Cmo & Cro Product Introduction 7.2.4 Boehringer Ingelheim GmbH Response to COVID-19 and Related Developments 7.3 Rentschler Biotechnologie GmbH 7.3.1 Rentschler Biotechnologie GmbH Business Overview 7.3.2 Rentschler Biotechnologie GmbH Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.3.3 Rentschler Biotechnologie GmbH Biopharmaceutical Cmo & Cro Product Introduction 7.3.4 Rentschler Biotechnologie GmbH Response to COVID-19 and Related Developments 7.4 Inno Biologics Sdn Bhd 7.4.1 Inno Biologics Sdn Bhd Business Overview 7.4.2 Inno Biologics Sdn Bhd Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.4.3 Inno Biologics Sdn Bhd Biopharmaceutical Cmo & Cro Product Introduction 7.4.4 Inno Biologics Sdn Bhd Response to COVID-19 and Related Developments 7.5 JRS Pharma (Celonic GmbH) 7.5.1 JRS Pharma (Celonic GmbH) Business Overview 7.5.2 JRS Pharma (Celonic GmbH) Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.5.3 JRS Pharma (Celonic GmbH) Biopharmaceutical Cmo & Cro Product Introduction 7.5.4 JRS Pharma (Celonic GmbH) Response to COVID-19 and Related Developments 7.6 BIOMEVA GmbH 7.6.1 BIOMEVA GmbH Business Overview 7.6.2 BIOMEVA GmbH Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.6.3 BIOMEVA GmbH Biopharmaceutical Cmo & Cro Product Introduction 7.6.4 BIOMEVA GmbH Response to COVID-19 and Related Developments 7.7 ProBioGen 7.7.1 ProBioGen Business Overview 7.7.2 ProBioGen Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.7.3 ProBioGen Biopharmaceutical Cmo & Cro Product Introduction 7.7.4 ProBioGen Response to COVID-19 and Related Developments 7.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. 7.8.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview 7.8.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.8.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical Cmo & Cro Product Introduction 7.8.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Response to COVID-19 and Related Developments 7.9 TOYOBO CO., LTD 7.9.1 TOYOBO CO., LTD Business Overview 7.9.2 TOYOBO CO., LTD Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.9.3 TOYOBO CO., LTD Biopharmaceutical Cmo & Cro Product Introduction 7.9.4 TOYOBO CO., LTD Response to COVID-19 and Related Developments 7.10 Samsung BioLogics 7.10.1 Samsung BioLogics Business Overview 7.10.2 Samsung BioLogics Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.10.3 Samsung BioLogics Biopharmaceutical Cmo & Cro Product Introduction 7.10.4 Samsung BioLogics Response to COVID-19 and Related Developments 7.11 Patheon 7.11.1 Patheon Business Overview 7.11.2 Patheon Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.11.3 Patheon Biopharmaceutical Cmo & Cro Product Introduction 7.11.4 Patheon Response to COVID-19 and Related Developments 7.12 CMC Biologics 7.12.1 CMC Biologics Business Overview 7.12.2 CMC Biologics Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.12.3 CMC Biologics Biopharmaceutical Cmo & Cro Product Introduction 7.12.4 CMC Biologics Response to COVID-19 and Related Developments 7.13 Binex Co., Ltd. 7.13.1 Binex Co., Ltd. Business Overview 7.13.2 Binex Co., Ltd. Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.13.3 Binex Co., Ltd. Biopharmaceutical Cmo & Cro Product Introduction 7.13.4 Binex Co., Ltd. Response to COVID-19 and Related Developments 7.14 AbbVie Inc. 7.14.1 AbbVie Inc. Business Overview 7.14.2 AbbVie Inc. Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.14.3 AbbVie Inc. Biopharmaceutical Cmo & Cro Product Introduction 7.14.4 AbbVie Inc. Response to COVID-19 and Related Developments 7.15 WuXi Biologics. 7.15.1 WuXi Biologics. Business Overview 7.15.2 WuXi Biologics. Biopharmaceutical Cmo & Cro Quarterly Production and Revenue, 2020 7.15.3 WuXi Biologics. Biopharmaceutical Cmo & Cro Product Introduction 7.15.4 WuXi Biologics. Response to COVID-19 and Related Developments 8 Supply Chain and Sales Channels Analysis 8.1 Biopharmaceutical Cmo & Cro Supply Chain Analysis 8.1.1 Biopharmaceutical Cmo & Cro Supply Chain Analysis 8.1.2 Covid-19 Impact on Biopharmaceutical Cmo & Cro Supply Chain 8.2 Distribution Channels Analysis 8.2.1 Biopharmaceutical Cmo & Cro Distribution Channels 8.2.2 Covid-19 Impact on Biopharmaceutical Cmo & Cro Distribution Channels 8.2.3 Biopharmaceutical Cmo & Cro Distributors 8.3 Biopharmaceutical Cmo & Cro Customers 9 Key Findings 10 Appendix 10.1 About Us 10.2 Disclaimer

List of Tables Table 1. Overview of the World Economic Outlook Projections Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 7. Covid-19 Impact: Global Major Government Policy Table 8. The Covid-19 Impact on Biopharmaceutical Cmo & Cro Assessment Table 9. COVID-19 Impact: Biopharmaceutical Cmo & Cro Market Trends Table 10. COVID-19 Impact Global Biopharmaceutical Cmo & Cro Market Size Table 11. Global Biopharmaceutical Cmo & Cro Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT) Table 12. Global Biopharmaceutical Cmo & Cro Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT) Table 13. Global Biopharmaceutical Cmo & Cro Quarterly Market Size, 2020 (US$ Million) & (K MT) Table 14. Global Biopharmaceutical Cmo & Cro Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million) Table 15. Global Biopharmaceutical Cmo & Cro Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT) Table 16. Global Biopharmaceutical Cmo & Cro Market Growth Drivers Table 17. Global Biopharmaceutical Cmo & Cro Market Restraints Table 18. Global Biopharmaceutical Cmo & Cro Market Opportunities Table 19. Global Biopharmaceutical Cmo & Cro Market Challenges Table 20. Key Manufacturers Biopharmaceutical Cmo & Cro Quarterly Revenue, 2019 VS 2020 (US$ Million) Table 21. Top Manufacturers, Biopharmaceutical Cmo & Cro Market Size, 2019 (K MT) & (US$ Million) Table 22. Biopharmaceutical Cmo & Cro Factory Price by Manufacturers 2020 (USD/MT) Table 23. Location of Key Manufacturers Biopharmaceutical Cmo & Cro Manufacturing Plants Table 24. Key Manufacturers Biopharmaceutical Cmo & Cro Market Served Table 25. Date of Key Manufacturers Enter into Biopharmaceutical Cmo & Cro Market Table 26. Key Manufacturers Biopharmaceutical Cmo & Cro Product Type Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Biopharmaceutical Cmo & Cro Market Size by Type, 2020, (US$ Million) Table 29. Global Biopharmaceutical Cmo & Cro Market Size by Type, 2020 (K MT) Table 30. Global Biopharmaceutical Cmo & Cro Price: by Type, 2020-2021 (USD/MT) Table 31. Global Biopharmaceutical Cmo & Cro Market Size by Application: 2020-2021 (US$ Million) Table 32. Global Biopharmaceutical Cmo & Cro Market Size by Application, 2020-2021 (K MT) Table 33. Global Biopharmaceutical Cmo & Cro Price: by Application, 2020-2021 (USD/MT) Table 34. Global Biopharmaceutical Cmo & Cro Market Size by Region, 2019-2021 (US$ Million) Table 35. Global Biopharmaceutical Cmo & Cro Market Size by Region, 2019-2021 (K MT) Table 36. By Country, North America Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) Table 37. By Country, North America Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (K MT) Table 38. US Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) & (K MT) Table 39. Canada Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) & (K MT) Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy) Table 41. By Country, Europe Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) Table 42. By Country, Europe Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (K MT) Table 43. Germany Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) & (K MT) Table 44. France Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) & (K MT) Table 45. UK Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) & (K MT) Table 46. Italy Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) & (K MT) Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN) Table 48. By Region, Asia-Pacific Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) Table 49. By Region, Asia-Pacific Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (K MT) Table 50. China Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) & (K MT) Table 51. Japan Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) & (K MT) Table 52. South Korea Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) & (K MT) Table 53. India Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) & (K MT) Table 54. ASEAN Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) & (K MT) Table 55. Latin America Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) & (K MT) Table 56. Middle East and Africa Biopharmaceutical Cmo & Cro Market Size, 2019-2021 (US$ Million) & (K MT) Table 57. Lonza Business Overview Table 58. Lonza Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 59. Lonza Biopharmaceutical Cmo & Cro Product Table 60. Lonza Response to COVID-19 and Related Developments Table 61. Boehringer Ingelheim GmbH Business Overview Table 62. Boehringer Ingelheim GmbH Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 63. Boehringer Ingelheim GmbH Biopharmaceutical Cmo & Cro Product Table 64. Boehringer Ingelheim GmbH Response to COVID-19 and Related Developments Table 65. Rentschler Biotechnologie GmbH Business Overview Table 66. Rentschler Biotechnologie GmbH Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 67. Rentschler Biotechnologie GmbH Biopharmaceutical Cmo & Cro Product Table 68. Rentschler Biotechnologie GmbH Response to COVID-19 and Related Developments Table 69. Inno Biologics Sdn Bhd Business Overview Table 70. Inno Biologics Sdn Bhd Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 71. Inno Biologics Sdn Bhd Biopharmaceutical Cmo & Cro Product Table 72. Inno Biologics Sdn Bhd Response to COVID-19 and Related Developments Table 73. JRS Pharma (Celonic GmbH) Business Overview Table 74. JRS Pharma (Celonic GmbH) Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 75. JRS Pharma (Celonic GmbH) Biopharmaceutical Cmo & Cro Product Table 76. JRS Pharma (Celonic GmbH) Response to COVID-19 and Related Developments Table 77. BIOMEVA GmbH Business Overview Table 78. BIOMEVA GmbH Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 79. BIOMEVA GmbH Biopharmaceutical Cmo & Cro Product Table 80. BIOMEVA GmbH Response to COVID-19 and Related Developments Table 81. ProBioGen Business Overview Table 82. ProBioGen Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 83. ProBioGen Biopharmaceutical Cmo & Cro Product Table 84. ProBioGen Response to COVID-19 and Related Developments Table 85. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview Table 86. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 87. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical Cmo & Cro Product Table 88. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Response to COVID-19 and Related Developments Table 89. TOYOBO CO., LTD Business Overview Table 90. TOYOBO CO., LTD Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 91. TOYOBO CO., LTD Biopharmaceutical Cmo & Cro Product Table 92. TOYOBO CO., LTD Response to COVID-19 and Related Developments Table 93. Samsung BioLogics Business Overview Table 94. Samsung BioLogics Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 95. Samsung BioLogics Biopharmaceutical Cmo & Cro Product Table 96. Samsung BioLogics Response to COVID-19 and Related Developments Table 97. Patheon Business Overview Table 98. Patheon Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 99. Patheon Biopharmaceutical Cmo & Cro Product Table 100. Patheon Response to COVID-19 and Related Developments Table 101. CMC Biologics Business Overview Table 102. CMC Biologics Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 103. CMC Biologics Biopharmaceutical Cmo & Cro Product Table 104. CMC Biologics Response to COVID-19 and Related Developments Table 105. Binex Co., Ltd. Business Overview Table 106. Binex Co., Ltd. Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 107. Binex Co., Ltd. Biopharmaceutical Cmo & Cro Product Table 108. Binex Co., Ltd. Response to COVID-19 and Related Developments Table 109. AbbVie Inc. Business Overview Table 110. AbbVie Inc. Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 111. AbbVie Inc. Biopharmaceutical Cmo & Cro Product Table 112. AbbVie Inc. Response to COVID-19 and Related Developments Table 113. WuXi Biologics. Business Overview Table 114. WuXi Biologics. Biopharmaceutical Cmo & Cro Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 115. WuXi Biologics. Biopharmaceutical Cmo & Cro Product Table 116. WuXi Biologics. Response to COVID-19 and Related Developments Table 117. Biopharmaceutical Cmo & Cro Distributors List Table 118. Biopharmaceutical Cmo & Cro Customers List Table 119. Covid-19 Impact on Biopharmaceutical Cmo & Cro Customers List of Figures Figure 1. Biopharmaceutical Cmo & Cro Product Picture Figure 2. Biopharmaceutical Cmo & Cro Market Segmentation Figure 3. Research Objectives Figure 4. Research Process Figure 5. Data Triangulation Figure 6. Research Approach Figure 7. Commodity Prices-Metals Price Indices Figure 8. Commodity Prices- Precious Metal Price Indices Figure 9. Commodity Prices- Agricultural Raw Material Price Indices Figure 10. Commodity Prices- Food and Beverage Price Indices Figure 11. Commodity Prices- Fertilizer Price Indices Figure 12. Commodity Prices- Energy Price Indices Figure 13. G20+: Economic Policy Responses to COVID-19 Figure 14. Global Biopharmaceutical Cmo & Cro Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million) Figure 15. Global Biopharmaceutical Cmo & Cro Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%) Figure 16. Global Biopharmaceutical Cmo & Cro Market Size, Quarterly Growth, 2020-2021 (%) Figure 17. Global Biopharmaceutical Cmo & Cro Market Size, Market Share by Type, 2019 VS 2020 (%) Figure 18. Global Biopharmaceutical Cmo & Cro Market Size, Market Share by Application, 2019 VS 2020 (%) Figure 19. Global Biopharmaceutical Cmo & Cro Market Size Market Share by Region, 2019 VS 2020 (%) Figure 20. United States Composite PMI and GDP Figure 21. Eurozone Composite PMI and GDP Figure 22. Eurozone Core v. Periphery PMI Output Indices Figure 23. Core v. Periphery PMI Employment Indices Figure 24. UK Composite PMI and GDP Figure 25. Caixin China Composite Output Index Figure 26. Caixin China General Services Business Activity Index Figure 27. Japan Composite Output Index Figure 28. South Korea Manufacturing PMI Figure 29. India Composite Output Index Figure 30. ASEAN Manufacturing PMI Figure 31. By Region, Asia-Pacific Biopharmaceutical Cmo & Cro Market Size Market Share, 2019-2021

Lonza Boehringer Ingelheim GmbH Rentschler Biotechnologie GmbH Inno Biologics Sdn Bhd JRS Pharma (Celonic GmbH) BIOMEVA GmbH ProBioGen FUJIFILM Diosynth Biotechnologies U.S.A., Inc. TOYOBO CO., LTD Samsung BioLogics Patheon CMC Biologics Binex Co., Ltd. AbbVie Inc. WuXi Biologics.